Search

Zai Lab Ltd ADR

Lezárt

SzektorEgészségügy

25.81 -0.62

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

25.75

Maximum

26.03

Fő mutatók

By Trading Economics

Bevétel

191K

-51M

Értékesítés

6.7M

106M

Egy részvényre jutó nyereség

-0.46

Profit margin

-47.808

Munkavállalók

1,784

EBITDA

-2.1M

-46M

Ajánlások

By TipRanks

Ajánlások

Erős vétel

12 hónapos előrejelzés

+26.06% upside

Osztalékok

By Acuity

Következő eredményjelentés

2026. nov. 5.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

593M

2.6B

Előző nyitás

26.43

Előző zárás

25.81

Zai Lab Ltd ADR Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. aug. 15. 00:06 UTC

News

Berkshire Hathaway increased its stake in New York Times Co. to 15.7 million shares, contributing to a modest rise in after-market hours.

2026. aug. 15. 00:02 UTC

News

AeroVironment appointed Michael D. Ruppert to its Board of Directors as Charles Burbage plans to retire in 2026. Shares are lower in after-market trading.

2026. aug. 15. 00:02 UTC

News

Shares of Photronics Inc lower in after-hours trading amid a class action lawsuit alleging securities fraud related to misleading statements about its product pipeline.

2026. aug. 15. 00:02 UTC

Social Media
News

Berkshire Hathaway's new position in DR Horton increased investor interest, contributing to a rise in the stock during after-hours trading.

2026. aug. 15. 00:02 UTC

News

Planet Fitness Inc. shares are higher in after-market trading, reflecting positive sentiment following recent performance despite remaining below the 20-day moving average.

2026. aug. 15. 00:02 UTC

News

Berkshire Hathaway has dissolved its stake in Constellation Brands, contributing to a decline in shares during after-market hours. The stock remains above its 20-day moving average.

2026. aug. 15. 00:02 UTC

News

Target Corp shares are lower in after-market hours despite Telsey Advisory Group raising its price target to $170 and maintaining an Outperform rating.

2026. aug. 15. 00:02 UTC

News

Realty Income Corp closed a $1.0 billion private offering of convertible senior notes and is trading higher in after-market hours.

2026. aug. 15. 00:02 UTC

News

Texas Pacific Land shares rise in after-market trading, continuing a trend of gains. The company's market cap stands at $24.75 billion.

2026. aug. 15. 00:01 UTC

News

Soros Fund Management LLC reduced its stake in Blue Owl Capital Inc by 51.8% to 973,500 shares, contributing to negative sentiment. Shares are roughly flat in after-market trading.

2026. aug. 15. 00:01 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise to 32.3 million shares. Shares were roughly flat in after-market trading.

2026. aug. 15. 00:01 UTC

News
Social Media

Genco Shipping & Trading shares decline in after-market trading following Diana Shipping's withdrawal of its acquisition offer due to unrealistic demands from Genco's Board.

2026. aug. 15. 00:01 UTC

News

Wix.Com Ltd faces a class action lawsuit over alleged securities law violations related to its AI products, with shares trading lower in after-market hours.

2026. aug. 15. 00:01 UTC

News

Jana Partners disclosed a new stake in Rapid7, contributing to positive sentiment. In after-market trading, shares recovered and traded higher since Friday's close.

2026. aug. 15. 00:01 UTC

News

Embecta Corp shares are lower in after-market trading amid two class action lawsuits alleging securities fraud and a significant revenue decline.

2026. aug. 14. 23:52 UTC

News

Boeing Co secures over $711 million in U.S. defense contract modifications, boosting investor sentiment. Shares are higher in after-market trading.

2026. aug. 14. 23:51 UTC

News

PayPal is in advanced talks for a potential sale to Stripe and Advent, following a proposal of $60.50 per share. Shares are higher in after-market trading.

2026. aug. 14. 23:51 UTC

News

Tyson Foods will close its beef facility in Joslin, Illinois, resulting in about 2,500 job losses, as shares trade lower in after-market hours.

2026. aug. 14. 23:46 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from a securities fraud lawsuit related to its RP1 application.

2026. aug. 14. 23:46 UTC

News

Delek US Holdings shares rose in after-market hours following Delek Logistics Partners' $230 million public offering of common units at $50.00 each.

2026. aug. 14. 23:46 UTC

News

Patterson-UTI Energy reported 98 drilling rigs operating in July. Shares rose in after-market trading, reflecting strong activity and nearing the upper end of their one-month range.

2026. aug. 14. 23:46 UTC

News

Kraft Heinz Co shares are lower in after-market trading following a $100 million marketing announcement and concerns over July's U.S. retail sales drop.

2026. aug. 14. 23:41 UTC

News

Elliott Investment Management increased its stake in Hewlett Packard Enterprise by 17.7%, contributing to higher after-market trading for the shares.

2026. aug. 14. 23:36 UTC

News

Dynatrace shares are higher in after-hours trading following Starboard Value's SEC filing disclosing an 8.9 million share stake.

2026. aug. 14. 23:31 UTC

News

Texas Pacific Land Corp shares are higher in after-market hours, with a current price of $358.89 and a market capitalization of $24.75 billion.

2026. aug. 14. 23:31 UTC

News

Jana Partners disclosed a new stake in Rapid7 Inc, acquiring over 6.7 million shares. Shares advanced during after-market hours following the announcement.

2026. aug. 14. 23:21 UTC

News

MongoDB Inc. showcases AI focus with new Atlas Managed MCP Server tools and Voyage AI features. Shares are little changed in after-market trading.

2026. aug. 14. 23:21 UTC

News

Constellation Brands shares are trading lower after Berkshire Hathaway dissolved its stake, contributing to negative sentiment amid broader weakness in the Distillers & Vintners sector.

2026. aug. 14. 23:21 UTC

News

Embecta Corp shares are lower in after-market hours amid negative sentiment from two class action lawsuits alleging securities fraud and disappointing second-quarter guidance.

2026. aug. 14. 23:11 UTC

News

Lattice Semiconductor granted over 414,000 RSUs and PRSUs to new employees as part of its equity incentive plan. Shares are trading roughly flat in after-market hours.

Társak összehasonlítása

Árváltozás

Zai Lab Ltd ADR Előrejelzés

Célár

By TipRanks

26.06% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 32.65 USD  26.06%

Magas 45 USD

Alacsony 21.6 USD

4 Wall Street elemző 12 hónapos célárain alapulva a(z)Zai Lab Ltd ADR termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Erős vétel

4 ratings

3

Vétel

1

Tartás

0

Eladás

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Zai Lab Ltd ADR

Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience. Its commercial products include Zejula, an orally administered poly polymerase 1/2 inhibitor; Optune, a cancer therapy that uses electric fields tuned to specific frequencies to kill tumor cells; NUZYRA for acute bacterial skin and skin structure infections, and community acquired bacterial pneumonia; Qinlock to treat gastrointestinal stromal tumors, and VYVGART, a human IgG1 antibody fragment for myesthenia gravis. The company also develops Tumor Treating Fields, a portable device for delivery of electric fields; Repotrectinib, a tyrosine kinase inhibitor (TKI) to target ROS1 and TRK A/B/C in TKI-naïve- or -pretreated cancer patients; Tisotumab vedotin, an antibody drug conjugate; Adagrasib for treating KRAS-G12C-mutated NSCLC, colorectal cancer, and pancreatic cancer; and Bemarituzumab to treat gastric and gastroesophageal junction cancer patients. In addition, it develops Sulbactam/durlobactam, a combination of a beta-lactam antibiotic and a beta-lactamase inhibitor for the treatment of serious infections caused by Acinetobacter; KarXT for the treatment of psychiatric and neurological conditions. It has license and collaboration agreement with Tesaro, Inc. to develop, manufacture, and commercialize niraparib; NovoCure to develop and commercialize Tumor Treating Fields; Deciphera to develop and commercialize ripretinib; Paratek Bermuda Ltd. to develop, manufacture, and commercialize omadacycline; argenx, to develop and commercialize efgartigimod; BMS to develop and commercialize tisotumab vedotin and repotrectinib; Mirati to research, develop, manufacture, and commercialize adagrasib; Amgen to develop and commercialize bemarituzumab; and Innoviva to develop and commercialize Sulbactam-Durlobactam; Karuna to develop and commercialize KarXT; and strategic collaboration with Pfizer for XACDURO. The company was incorporated in 2013 and is headquartered in Shanghai, China.
help-icon Live chat